- ￥1788.80
- BioXCell
- 美国
- BE0322-1mg
- 2025年07月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
详询
- 保质期：
详询
- 英文名：
InVivoMAb anti-mouse CD172a (SIRPα)
- 库存：
99
- 供应商：
北京孚博生物
- CAS号：
详询
- 规格：
1mg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Immunofluorescence: Rabbit Anti-Murine RELMα
for 25 minutes. 3. Incubate the tissue section with blocking buffer for 20 minutes. 4. Incubate the tissue section overnight at 4?C with Rabbit Anti-Murine RELMα at 4.0 ng/mL in 1X PBS with 0.01% Triton-X and 0.5% BSA. Wash the slide
Isolation of Mouse Thymic Dendritic Cell Precursors
regulatory T cells. DC in the thymus are comprised of plasmacytoid DC (pDC) and conventional DC (cDC) populations. The cDC can be divided into two populations based on the expression of CD8α and Sirpα: CD8α+ Sirpαl � (∼70%) and CD8αl � Sirpα+ (∼30%). The CD8α
Genotyping Anti-Hepatitis B Virus Drug Resistance
Agents available or in development for the treatment of chronic hepatitis B virus (HBV) infection fall into two major groups: immunomodulators, such as interferon-α and therapeutic vaccines, and nucleoside/nucleotide analogs
技术资料暂无技术资料 索取技术资料
